Armstrong Advisory Group’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$36.2K Buy
379
+3
+0.8% +$288 ﹤0.01% 491
2026
Q1
$39K Buy
376
+1
+0.3% +$113 ﹤0.01% 452
2025
Q4
$37.8K Buy
375
+2
+0.5% +$217 ﹤0.01% 442
2025
Q3
$46K Buy
373
+2
+0.5% +$248 ﹤0.01% 411
2025
Q2
$44.5K Sell
371
-35
-9% -$4.67K ﹤0.01% 397
2025
Q1
$65.9K Hold
406
0.01% 333
2024
Q4
$65.9K Hold
406
0.01% 333
2024
Q3
$66.1K Hold
406
0.01% 328
2024
Q2
$55.4K Sell
406
-38
-9% -$5.28K ﹤0.01% 343
2024
Q1
$63.3K Hold
444
0.01% 311
2023
Q4
$63.3K Hold
444
0.01% 311
2023
Q3
$58.2K Sell
444
-8
-2% -$1.22K 0.01% 314
2023
Q2
$71.9K Sell
452
-79
-15% -$12.7K 0.01% 289
2023
Q1
$84K Sell
531
-38
-7% -$5.7K 0.01% 261
2022
Q4
$79.8K Buy
+569
New +$80.8K 0.01% 263

Other funds holding CLX

Armstrong Advisory Group's CLX Position: Q2 2026 in Review

Armstrong Advisory Group increased its Clorox (CLX) stake by 0.8% in Q2 2026, buying an estimated $288 and bringing the position to 379 shares worth $36.2K. The position accounts for ﹤0.01% of the portfolio, ranked #491.

Armstrong Advisory Group first reported a position in CLX in Q4 2022 and has held it in 15 quarters since. The position peaked at $84K in Q1 2023. 175 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Armstrong Advisory Group held 379 shares of Clorox worth $36.2K as of Q2 2026.
  • Armstrong Advisory Group bought 3 Clorox shares in Q2 2026, an estimated $288.
  • Clorox made up ﹤0.01% of Armstrong Advisory Group's portfolio in Q2 2026, its #491 holding.
  • Armstrong Advisory Group first reported a position in Clorox in Q4 2022 and has held it in 15 quarters since.
  • Armstrong Advisory Group's Clorox position peaked at $84K in Q1 2023.
  • 175 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Armstrong Advisory Group's 13F filing for Q2 2026, filed 13 Jul 2026.